Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer

Sun Yat-sen University · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
ovariancancerplatinumresistant
ovarian cancer, ovarian carcinoma, platinum-resistant ovarian cancer, fallopian tube carcinosarcoma, primary peritoneal cancer, parp inhibitor, antiangiogenic agents, platinum-resistant, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 831976
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.